tiprankstipranks
Nuo Therapeutics (AURX)
OTHER OTC:AURX
US Market
Holding AURX?
Track your performance easily

Nuo Therapeutics (AURX) Financial Statements

11 Followers

Nuo Therapeutics Financial Overview

Nuo Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.056; its P/E ratio is ―; Nuo Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 370.95K$ 364.77K$ 197.01K$ 232.24K$ 118.17K
Gross Profit$ 270.45K$ 299.44K$ 155.65K$ 178.42K$ 97.68K
EBIT$ -578.17K$ -540.09K$ -1.03M$ -789.55K$ -871.89K
EBITDA$ -557.70K$ -520.19K$ -1.01M$ -763.16K$ -845.87K
Net Income Common Stockholders$ -578.17K$ -540.09K$ -653.15K$ -790.64K$ -871.89K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 683.84K$ 473.04K$ 928.68K$ 582.59K$ 399.37K
Total Assets$ 1.72M$ 1.42M$ 1.88M$ 1.60M$ 1.39M
Total Debt$ 179.31K$ 194.04K$ 255.59K$ 276.20K$ 296.31K
Net Debt$ -504.53K$ -279.00K$ -673.09K$ -306.39K$ -103.06K
Total Liabilities$ 828.72K$ 821.96K$ 838.73K$ 873.18K$ 914.44K
Stockholders Equity$ 890.39K$ 598.51K$ 1.04M$ 726.72K$ 470.83K
Cash Flow-
Free Cash Flow$ -638.33K$ -695.27K$ -671.41K$ -796.78K$ -905.89K
Operating Cash Flow$ -487.47K$ -691.17K$ -671.41K$ -794.88K$ -905.89K
Investing Cash Flow$ -150.86K$ -4.10K-$ -1.90K-
Financing Cash Flow$ 849.13K$ 802.08K$ 962.50K$ 1.03M-
Currency in USD

Nuo Therapeutics Earnings and Revenue History

Nuo Therapeutics Debt to Assets

Nuo Therapeutics Cash Flow

Nuo Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis